Skip to Main Content

Paper Details

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.
Oncotarget
18
2016
Eribulin, Osteosarcoma, P-glycoprotein, P-gp, STMN1, TUBB3, bone cancer, children, cyclin-dependent kinase, eribulin, eribulin-sensitive and -resistant osteosarcoma xenograft tumors, human, human osteosarcoma cell lines, microtubule, osteosarcoma, p27, patients, pediatric, stathmin-1, tubulin
Author NameAffiliation
Wendong ZhangThe Children's Hospital at Montefiore, The Albert Einstein College of Medicine
Richard GorlickThe Children's Hospital at Montefiore, The Albert Einstein College of Medicine
Richard GorlickThe Children's Hospital at Montefiore, The Albert Einstein College of Medicine
Edward A KolbNemours Center for Cancer and Blood Disorders, Nemours/A.I. duPont Hospital for Children
  • 1 - 4

Datasets

Release 1.2